Fundraising Fox
CellCentric
58 employees on LinkedIn · 9 known investors
Find your way into CellCentric
Sign up to find every way you can get introduced to CellCentric
- Your email: who you already know at CellCentric, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CellCentric team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers. The company focuses on cell fate control mechanisms to identify novel targets for cancer treatments and works with scientific and clinical centers of excellence.
Founders & leadership
Investors · 9
How we know: Avego BioScience Capital's portfolio page · Not right? Tell us
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us
How we know: HBM Partners's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · Not right? Tell us
How we know: open dataset · investor-profiles · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$440M disclosed across 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does CellCentric do?
- CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers. The company focuses on cell fate control mechanisms to identify novel targets for cancer treatments and works with scientific and clinical centers of excellence.
- Who founded CellCentric?
- CellCentric was founded by Azim Surani.
- Who are CellCentric's investors?
- CellCentric's investors include Avego BioScience Capital, Future Planet Capital, HBM Healthcare Investments, HBM Partners, RA Capital, Sofinnova Partners, BrightEdge, Forbion and 1 more.
- How much funding has CellCentric raised?
- CellCentric has disclosed $440M raised across 2 rounds.